Objective To evaluate the papers reporting traditional Chinese medicine（TCM） drug-induced liver injury（DILI） in China

and to provide references for developing reporting standards of TCM DILI. Methods Terms including "Chinese herbal medicine（中药）"

"drugs（药物）"

and "liver damage（肝损伤）" were searched in CNKI for papers reporting TCM DILI. The basic characteristics regarding to the disease history

use of health-care products

drinking history

medications of both TCM and western medicine

source of Chinese medicinals and its identification were collected

and the problems in reporting TCM DILI were summarized. Results Totally

327 reports on TCM DILI were included. The number of papers reporting history of multiple diseases was 186（56.9%）

while that of history of multiple drugs

use of health-care products

drinking history

TCM medication history

use of western medicine drugs was 180（55.0%）

57（17.4%）

110（33.6%）

192（58.7%）

and 171（52.3%）

respectively. Information on manufacturers

batch numbers

dosage

duration

source of Chinese medicinals

and identification were reported in 21（6.4%）

15（4.6%）

95（29.1%）

253（77.4%）

9（2.8%） and 8（2.4%） papers respectively. One hundred and forty（42.8%） papers reported the correlation between TCM and DILI. Sixty nine papers were by clinical researchers

while 257 were retrospective studies based on medical records

and one was based on adverse drug reaction report（78.9%）. Conclusion Current TCM DILI papers have not comprehensively reported both DILI-related patients′ information and TCM information

and mostly lacked the information on drug-related adverse reactions or adverse events

indicating a low reliability of the reporting. In future studies

full information on Chinese herbal medicine should be reported

confounding factors of western medicine should be excluded

and the standard procedures for reporting TCM DILI must be implemented.